(19)
(11) EP 4 334 468 A2

(12)

(88) Date of publication A3:
12.01.2023

(43) Date of publication:
13.03.2024 Bulletin 2024/11

(21) Application number: 22799461.3

(22) Date of filing: 03.05.2022
(51) International Patent Classification (IPC): 
C12Q 1/6806(2018.01)
C12Q 1/00(2006.01)
C12Q 1/6874(2018.01)
C12N 9/22(2006.01)
C12Q 1/68(2018.01)
C12Q 1/6886(2018.01)
(52) Cooperative Patent Classification (CPC):
C12Q 1/6886; G16B 20/00; G16B 40/00
(86) International application number:
PCT/US2022/027536
(87) International publication number:
WO 2022/235718 (10.11.2022 Gazette 2022/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 03.05.2021 US 202163183610 P
06.08.2021 US 202163230584 P

(71) Applicants:
  • The Regents of The University of California
    Oakland CA 94607-5200 (US)
  • Wellcome Sanger Institute
    Hinxton, Cambridgeshire CB10 1SA (GB)

(72) Inventors:
  • AHITUV, Nadav
    Walnut Creek, CA (US)
  • YIZHAR-BARNEA, Ofer
    Foster City, CA 94404 (US)
  • GEORGAKOPOULOS-SOARES, Ilias
    San Francisco, CA 94158 (US)
  • MOURATIDIS, Ioannis
    1150 Brussels (BE)
  • HEMBERG, Martin
    Weston, MA 02493 (US)

(74) Representative: Leonard, Thomas Charles et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) COMPOSITIONS COMPRISING NULLOMERS AND METHODS OF USING THE SAME FOR CANCER DETECTION AND DIAGNOSIS